menu
    • menu

    Company profile for Tavotek Biotherapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Tavotek has a rich pipeline of product candidates in various stages of development, focused on cancers, autoimmune conditions, and infectious diseases. Company management and advisors are veteran pharmaceutical exe...
    Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Tavotek has a rich pipeline of product candidates in various stages of development, focused on cancers, autoimmune conditions, and infectious diseases. Company management and advisors are veteran pharmaceutical executives with multiple prior successes in the development of many blockbuster biologics currently in the market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tavotek BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    727 Norristown Road 3 Spring House Innovation Park, Suite 101 Lower Gwynedd, P...
    Telephone
    Telephone
    267-405-9426
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tavotek.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Navrogen Inc. and Tavotek Biotherapeutics Announce Strategic Collaboration
    Navrogen Inc. and Tavotek Biotherapeutics Announce Strategic Collaboration

    17 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/navrogen-inc-and-tavotek-biotherapeutics-announce-strategic-collaboration-to-improve-therapeutic-efficacy-of-antibody-pipeline-agents-301356873.html

    PRNEWSWIRE
    17 Aug 2021
    Share Share
    Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing
    Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing

    22 Mar 2021

    // PRNASIA

    https://en.prnasia.com/releases/global/tavotek-biotherapeutics-announces-completion-of-round-a1-and-a2-financing-with-over-20-million-dollars-312253.shtml

    PRNASIA
    22 Mar 2021
    Share Share
    Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing
    Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing

    22 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/tavotek-biotherapeutics-announces-completion-of-round-a1-and-a2-financing-with-over-20-million-dollars-301250774.html

    PRNEWSWIRE
    22 Mar 2021
    Share Share
    Tavotek inks research pact with Genmab to develop bispecific antibodies
    Tavotek inks research pact with Genmab to develop bispecific antibodies

    27 May 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=126387&sid=2

    PHARMABIZ
    27 May 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search